Olisaemeka Dilibe Ogbue, MBBS

Olisaemeka Ogbue practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Olisaemeka Ogbue's NPI, 1578132981, was assigned on June 21, 2021. Olisaemeka Ogbue holds Minnesota license 76340.

Olisaemeka Ogbue's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Olisaemeka Ogbue's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Olisaemeka Ogbue is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Olisaemeka Ogbue to 1 more clinical lab and 1 hospice, each named with a free account. Olisaemeka Ogbue's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Olisaemeka Ogbue practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Olisaemeka Ogbue's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Olisaemeka Ogbue is licensed in Minnesota.

CMS data shows 39 Medicare services from Olisaemeka Ogbue across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $2,909 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Olisaemeka Ogbue in 2024. The largest group is 65 to 74, with 22 patients. 70% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Olisaemeka Ogbue's median patient age at 68, with 50% women.

In 2024, Olisaemeka Ogbue wrote 131 Medicare Part D claims for 50 patients. 80% of them were for generic drugs.

Olisaemeka Ogbue accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Olisaemeka Ogbue, published from 2020 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Leukemia, Large Granular Lymphocytic and Leukemia, Myeloid, Acute. Olisaemeka Ogbue has published most often in Cureus. Olisaemeka Ogbue's most frequent co-authors are Ramsha Tahoor Ahmed, MD, Taha Bat, MD and Hamed A. Daw, MD.

CMS Open Payments shows 34 general payments to Olisaemeka Ogbue from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $297.